Pulmonális artériás hipertónia: vizsgálatok itt: Portugália
8 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 15.. Ask the study team whether a trial fits you.
- 1/2. fázisTaking peopleA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Almada, Lisbon, Porto
- Életkor
- 18 év and over
- People
- 85 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2024-513613-12-00 - 4. fázisTaking peopleInitial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
- Where
- Almada, Lisbon
- Életkor
- 18 év to 75 év
- People
- 110 worldwide
- Run by
- AOP Orphan Pharmaceuticals AG
See details and how to joinNCT06317805 · EU 2023-504351-26-01 - 3. fázisTaking peopleEfficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Where
- Almada, Lisbon
- Életkor
- 18 év and over
- People
- 344 worldwide
- Run by
- Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00 - 3. fázisTaking peopleA Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
- Where
- Almada, Coimbra, Porto
- Életkor
- 18 év to 80 év
- People
- 344 worldwide
- Run by
- Liquidia Technologies, Inc.
See details and how to joinNCT07285655 - 3. fázisFut, nem toborozOpen-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
- Where
- Coimbra, Lisbon, Porto, Vila Nova de Gaia
- Életkor
- 18 év to 75 év
- People
- 330 worldwide
- Run by
- Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00 - 3. fázisFut, nem toborozA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Almada, Coimbra, Lisbon, Porto
- Életkor
- 18 év and over
- People
- 1000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00 - 3. fázisTaking peopleAn Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
- Where
- Almada, Lisbon, Porto
- Életkor
- 18 év to 75 év
- People
- 486 worldwide
- Run by
- Inhibikase Therapeutics
See details and how to joinNCT07365332 · EU 2024-520218-23-00 - 1/2. fázisTaking peopleA Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
- Where
- Almada, Lisbon
- Életkor
- 18 év to 100 év
- People
- 232 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06649110